FDA.reportPublic FDA data

CD22 cell marker IVD, antibody

Definition
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of CD22 cell marker in a clinical specimen.
GUDID devices
20
Last updated
2026-08-08 10:09:09

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
05700572024613Mono Mo A-Hu CD22/APC Cl 4KB128AGILENT TECHNOLOGIES SINGAPORE PTE LTDC72812020-09-17
05055331334718BOND™LEICA BIOSYSTEMS NEWCASTLE LTDPA0249-U2022-12-16
10190302010863Human CD22 FITC ConjugateLIFE TECHNOLOGIES CORPORATIONMHCD22012018-05-06
10190302010870Human CD22 R-PE ConjugateLIFE TECHNOLOGIES CORPORATIONMHCD22042018-05-06
10190302010887Human CD22 R-PE ConjugateLIFE TECHNOLOGIES CORPORATIONMHCD220442018-05-06
10190302010894Human CD22 APC ConjugateLIFE TECHNOLOGIES CORPORATIONMHCD22052018-05-06
00810119676054ANTI-CD22BIOGENEX LABORATORIESMU962-UC2023-05-08
00810119674333ANTI-CD22BIOGENEX LABORATORIESMU962-5UC2023-04-19
00847627003720CD22 [BLCAM/1796]BIOCARE MEDICAL LLCACI3229B2022-12-07
00847627004864CD22 [BLCAM/1796]BIOCARE MEDICAL LLCAPI3229AA2022-12-07
00382906639790HorizonBecton, Dickinson And Company6639792020-11-11
00382906645388N/ABecton, Dickinson And Company6645382021-07-23
05055331304421BOND™LEICA BIOSYSTEMS NEWCASTLE LTDPA02492021-03-12
05700572515876Mono Mo A-Hu CD22/FITC Cl 4KB128AGILENT TECHNOLOGIES SINGAPORE PTE LTDF70602020-09-17
05700572516323Mono Mo a Hu CD22/RPE, Cl 4KB128AGILENT TECHNOLOGIES SINGAPORE PTE LTDR70612020-09-17
05700573002245Mono Mo A-Hu CD22/PerCP-Cy5.5 Cl 4KB128AGILENT TECHNOLOGIES SINGAPORE PTE LTDPR7072020-09-17
00382903407071N/ABecton, Dickinson And Company3407072018-11-28
00382903407088N/ABecton, Dickinson And Company3407082018-11-28
00382903409327N/ABecton, Dickinson And Company3409322018-11-28
00382906563118N/ABecton, Dickinson And Company6563112018-11-28